All In Biotech

Free tool

FAERS Monitor: Upneeq

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 212520 or its brand name (Upneeq, Oxymetazoline Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

2,364

Serious

105

4% of reports

Hospitalization

11

Death reported

2

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective618
  • vision blurred311
  • eye irritation276
  • ocular hyperaemia257
  • off label use199
  • headache197
  • dry eye186
  • eye pain183
  • mydriasis130
  • eye pruritus119
  • lacrimation increased90
  • swelling of eyelid88
  • eye swelling70
  • dizziness59
  • blood pressure increased50

Reports by year received

View as table
YearReports
202034
2021370
2022439
2023292
2024318
2025274
2026637

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,795 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
swelling of eyelidSignal88126.5102.910,679
mydriasisSignal13091.177.011,379
ocular hyperaemiaSignal25748.443.111,855
eye irritationSignal27642.938.411,220
dry eyeSignal18633.329.05,782
eye pruritusSignal11931.626.53,491
eye painSignal18328.925.24,907
lacrimation increasedSignal9026.621.72,186
vision blurredSignal31120.218.25,679
eye swellingSignal7016.813.31,022
drug ineffectiveSignal6184.23.91,587
blood pressure increasedSignal502.92.261
headacheSignal1972.82.4232
off label useSignal1992.01.8106
dizziness591.10.80

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.